AFP and hepatocellular carcinoma: Moreover, the ASAP score demonstrated a better performance to discriminate AFP-negative HCC from HCC arising in the setting of cirrhosis (AUC of ASAP = 0.796 vs. AUC of GALAD = 0.752, P < 0.01) compared with the GALAD score with a sensitivity of 61.2% versus 76.3% and specificity of 87.1% versus 66.9%, respectively.